Elan to sell Westmeath unit to US firm, 400 jobs 'safe'

Athlone-based pharmaceutical company Elan is selling its Westmeath unit to US biotechnology firm Alkermes.

Elan to sell Westmeath unit to US firm, 400 jobs 'safe'
Mon, 09 May, 2011 - 13:23

Athlone-based pharmaceutical company Elan is selling its Westmeath unit to US biotechnology firm Alkermes.

It is understood Elan will be retaining a 25% share in the business, which employs 400 staff in Athlone.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

Benefit image

Limited offer valid for new and returning customers. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €12/month. Ts&Cs apply.

WhatsApp logo

Irish Examiner’s WhatsApp channel

More in this section

Donald Trump visit to Ireland Taoiseach: Trump would be 'welcomed' as Doonbeg confirmed as 2026 Irish Open venue
Ireland's population could reach over 7.5m by 2065, report suggests Ireland's population could reach over 7.5m by 2065, report suggests
Challenges against major projects go against common good, says Taoiseach  Challenges against major projects go against common good, says Taoiseach 
CourtsHeathrowPlace: USPlace: AthlonePerson: TDPerson: Nicky McFaddenOrganisation: ElanOrganisation: AthloneOrganisation: AlkermesOrganisation: Alkermes PLCOrganisation: Elan Drug TechnologiesOrganisation: Midlands 103
<p>The proposed site of the Cork Events centre beside Beamish and Crawford last year. The long-delayed project has entered a fresh procurement process. Picture: Chani Anderson</p>

Project management delivery team appointed for long-delayed Cork Events Centre project

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited